Filing Flows › Strata Critical Medical (SRTA) › Q3 2026 › vs Q3 2025
Strata Critical Medical (SRTA) Q3 2026 vs Q3 2025 (year over year)
Strata Critical Medical's revenue rose $24.8M (+50%) from $49.3M in Q3 2025 to $74.1M in Q3 2026. The biggest changes: Clinical +$26.4M (+946%); Logistics −$1.6M (-3%).
Strata Critical Medical, Q3 2026: revenue $74.1M (+50% year over year), operating margin -5.2%, net loss $7.6M, operating cash flow $9.5M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Logistics | $44.9M | $46.5M | −$1.6M | -3% |
| Clinical | $29.2M | $2.8M | $26.4M | +946% |
| Revenue | $74.1M | $49.3M | $24.8M | +50% |
| Net loss | $7.6M | −$57.4M | $65.0M | — |
| Costs & expenses | $81.7M | $112M | −$30.6M | -27% |
| Operating costs | $77.9M | $54.9M | $23.0M | +42% |
| Interest & other, net | $3.8M | −$63.0M | $66.8M | — |
| Cost of revenue | $57.3M | $38.6M | $18.6M | +48% |
| SG&A | $15.1M | $15.9M | −$772K | -5% |
| Other operating costs | $5.5M | $364K | $5.1M | 15× |
| Operating cash sources | $17.1M | −$94.7M | $112M | — |
| Depreciation & amortization | $7.3M | $1.7M | $5.6M | +329% |
| Share-based compensation | $5.0M | $1.7M | $3.4M | +201% |
| Working capital & other | $4.7M | −$98.1M | $103M | — |
| Net loss absorbed | $7.6M | −$57.4M | $65.0M | — |
| Operating cash flow | $9.5M | −$37.3M | $46.8M | — |
Questions
How much did Strata Critical Medical's revenue grow year over year in Q3 2026?
Strata Critical Medical's revenue rose $24.8M (+50%) from $49.3M in Q3 2025 to $74.1M in Q3 2026.
What drove Strata Critical Medical's revenue change in Q3 2026?
Clinical +$26.4M (+946%); Logistics −$1.6M (-3%).